<https://www.karyopharm.com/#organization>
<http://schema.org/sameAs>
<https://www.karyopharm.com/resources/preclinical-activity-non-hodgkins-lymphoma-selinexor-selective-inhibitor-nuclear-export-sine-enhanced-combination-standard-care-therapies/>